Regions of gliosis surround deposits of beta-amyloid peptide (beta AP)
in senile plaques of Alzheimer's disease (AD). The association betwee
n reactive astrocytes and beta AP in senile plaques is most pronounced
in cortex and hippocampus but not at other anatomical sites of beta A
P deposition. We hypothesized that this region-specific pathology in A
D could be attributed to differences in glial reactivity in different
parts of the central nervous system (CNS). To test this hypothesis, we
assayed astrocytes from cerebral cortex, hippocampus, cerebellum, and
spinal cord for cellular responsiveness to substrate-bound beta AP in
vitro. Astrocyte reactivity was monitored by morphological changes, i
ncreased deposition of chondroitin sulfate proteoglycan-containing mat
rix, and alterations in proteoglycan metabolism. Based on these criter
ia, only cortical and hippocampal astrocytes showed marked reactivity
to immobilized beta AP. In cortical and hippocampal cultures only, imm
obilized beta AP resulted in increased total radiosulfate incorporatio
n into proteoglycans which was mainly found in the cell/matrix rather
than in the media-associated compartment. There were also differences
in the proteoglycan synthesis patterns of astrocyte cultures isolated
from these CNS regions. These findings suggest that (1) astrocytes are
regionally heterogenous in their reactive response to beta AP and (2)
that specific molecules, in addition to beta AP, may exist following
trauma or disease which trigger reactive states in astroglia in the ce
rebellum or spinal cord. These local differences in the interaction be
tween beta AP and surrounding astrocytes may play a role in the region
-specific pathogenesis of Alzheimer's disease. (C) 1994 Academic Press
, Inc.